CAS RN: 2126161-28-0
4-bromo-3-ethenylpyridin-2-ol
Product Availability
Choose a grade to view its available package options.
1 package records 0 with current stock 1 grade group
Grade
97% (1)
In stock only
Batch No. Package Availability Lead Time Inquiry
Batchno.20260413
100mg / 250mg / 500mg
Out of stock
1 business days Inquiry
GET A QUOTE
This product has historical factory records. Recorded pack sizes and purity can be used as a supply reference, while project-specific availability is confirmed by inquiry.
Pack sizes on record: 1g
Available purity: ≥95%
Inventory rows with stock: 0
Bulk packaging: confirmed by inquiry
Request Bulk Quote
Recorded sizes, purity and stock details for CAS 2126161-28-0
Pack Size
Recorded Purity
Available Qty
Ship From
Inquiry
1g
≥95%
0
Out of Stock
Hong Kong
Inquiry
2126161-28-0 / 4-bromo-3-ethenyl-1H-pyridin-2-one
Standard CAS: 2126161-28-0
Multi CAS: No
Basic Information
copy
CAS
2126161-28-0 copy
Multi CAS
No copy
Molecular Formula
C7H6BrNO copy
Molecular Weight
200.030000 copy
Exact Mass
198.963280 copy
SMILES
C=CC1=C(C=CNC1=O)Br copy
InChI
InChI=1S/C7H6BrNO/c1-2-5-6(8)3-4-9-7(5)10/h2-4H,1H2,(H,9,10) copy
InChIKey
VMDNACBOMPHTRF-UHFFFAOYSA-N copy
Computed Properties
copy
Structural Parameters
Heavy atom count
10 copy
Aromatic heavy atom count
6 copy
Rotatable bonds
1 copy
H-bond acceptors
1 copy
H-bond donors
1 copy
Molar refractivity
44.85 copy
TPSA
32.86 copy
LogP / Solubility
WLOGP
1.78 copy
MLOGP
1.57 copy
XLogP3
1.4 copy
Consensus LogP
1.58 copy
Log S (ESOL)
-2.58 copy
Class (ESOL)
Moderately soluble copy
Log S (Ali)
-2.49 copy
Class (Ali)
Moderately soluble copy
Log S (SILICOS-IT)
-2.56 copy
Class (SILICOS-IT)
Moderately soluble copy
ADME
GI absorption
High copy
BBB permeant
Yes copy
P-gp substrate
No copy
CYP1A2 inhibitor
No copy
CYP2C19 inhibitor
No copy
CYP2C9 inhibitor
No copy
CYP2D6 inhibitor
No copy
CYP3A4 inhibitor
No copy
Log Kp (skin permeation)
-2.68 copy
Drug-likeness / Medicinal Chemistry
Lipinski
Yes copy
Ghose
No copy
Veber
Yes copy
Egan
Yes copy
Muegge
Yes copy
Bioavailability score
0.55 copy
Leadlikeness
No copy
Synthetic Accessibility
1.5 copy